Regeneron Research Facility

Philadelphia, Pennsylvania 19104

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Severe Hypertriglyceridemia (sHTG) Clinical Trial
Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lymphoma Clinical Trial
Study of REGN2810 and REGN1979 in Patients With Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Regeneron Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials